AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1873454 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated counselling and use of nicotine gum
Number of subjects: 923
Study 1873454 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated counselling and spirometry
Number of subjects: 923
Study 6867983 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 200 micrograms
Number of subjects: 8
Study 6867983 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 400 micrograms
Number of subjects: 8
Study 6867983 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 800 micrograms
Number of subjects: 8
Study 6867983 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol 1600 micrograms
Number of subjects: 8
Study 6867983 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (all doses)
Number of subjects: 8
Study 6867983 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple spirometric tests
Number of subjects: 8
Study 30653490 — intervention group
Group type: EXPERIMENTAL
Intervention: AmBisome monotherapy (40 mg/kg)
Number of subjects: 58
Study 30653490 — intervention group
Group type: EXPERIMENTAL
Intervention: AmBisome (30 mg/kg) with miltefosine (100 mg/day for 28 days)
Number of subjects: 58
Study 28070922 — intervention group
Group type: EXPERIMENTAL
Intervention: Hopping and jumping training programme (HJP)
Number of subjects: 3
Study 28070922 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorimotor rehabilitation programme (SRP)
Number of subjects: 3
Study 28070922 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study 27418594 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalcetrapib
Number of subjects: 5414
Study 27418594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5414
Study 24694769 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (TAT; DAT with cilostazol)
Number of subjects: 914
Study 24694769 — intervention group
Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (DAT; aspirin and clopidogrel)
Number of subjects: 914
Study 22480130 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT) in doses proportional to daily opioid doses (group P)
Number of subjects: 82
Study 22480130 — intervention group
Group type: COMPARATOR
Intervention: Dose titration of FBT starting with an initial dose of 100 µg (group T)
Number of subjects: 82
Study 20702512 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi exercise (60 minutes/session, three sessions/week, n = 30)
Number of subjects: 61
Study 20702512 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 31)
Number of subjects: 61
Study 18566931 — intervention group
Group type: EXPERIMENTAL
Intervention: Short exercise technique (15-minute sessions of short steps with arms unsupported)
Number of subjects: 0
Study 18566931 — intervention group
Group type: COMPARATOR
Intervention: Both stepping techniques (Short and Full)
Number of subjects: 0
Study 16195824 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 mg of GnRH agonist triptorelin acetate depot (Group I)
Number of subjects: 81
Study 16195824 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mg triptorelin acetate daily (Group II)
Number of subjects: 81
Study 11788184 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous estrogen-progestin therapy (Conjugated Equine Estrogens and Medroxyprogestin without interruption)
Number of subjects: 104
Study 11788184 — intervention group
Group type: COMPARATOR
Intervention: Sequential regimen (Conjugated Equine Estrogens over 25 days with Medroxyprogestin beyond the 14th day)
Number of subjects: 104
Study 9494450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium
Number of subjects: 10
Study 9494450 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study 8067712 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP-45, 10 mg administered intravenously between the seventh and third day prior to surgical treatment.
Number of subjects: 101
Study 8067712 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP-45 (treatment group)
Number of subjects: 101
Study 8067712 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study 2926518 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (10-minute per day home training program for six weeks)
Number of subjects: 45
Study 2926518 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 45
Study 1092425 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimorazole (1 g orally at 12-hourly intervals for three doses)
Number of subjects: 100
Study 1092425 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (200 mg three times daily for 7 days)
Number of subjects: 100
Study 30375890 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (15g daily for 7 weeks)
Number of subjects: 99
Study 30375890 — intervention group
Group type: COMPARATOR
Intervention: Control (usual diet)
Number of subjects: 99
Study 28697832 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine transdermal patch
Number of subjects: 134
Study 28697832 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol tablets
Number of subjects: 134
Study 28586587 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Myringotomy (LM)
Number of subjects: 130
Study 28586587 — intervention group
Group type: COMPARATOR
Intervention: Ventilation Tubes (VT)
Number of subjects: 130
Study 24433324 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact force (CF) catheter (SmartTouch Thermocool, Biosense Webster)
Number of subjects: 60
Study 24433324 — intervention group
Group type: COMPARATOR
Intervention: Non-CF open‐irrigated catheter (EZ Steer Thermocool, Biosense Webster)
Number of subjects: 60
Study 22285857 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic nitrate (8 mmol KNO3)
Number of subjects: 14
Study 22285857 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8 mmol KCl)
Number of subjects: 14
Study 18692790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hormone therapy (5 microg of ethinyl E(2) and 1 mg of norethindrone acetate)
Number of subjects: 10
Study 18692790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 17717453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 165
Study 17717453 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 165
Study 15313106 — intervention group
Group type: EXPERIMENTAL
Intervention: Print program
Number of subjects: 399
Study 15313106 — intervention group
Group type: EXPERIMENTAL
Intervention: Print plus Telephone program
Number of subjects: 399
Study 11806479 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide in experimental dentifrice
Number of subjects: 4
Study 11806479 — intervention group
Group type: COMPARATOR
Intervention: 3% hydrogen peroxide with 5% baking soda in experimental dentifrice
Number of subjects: 4
Study 9286859 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal betamethasone (12 mg at a 12-h interval)
Number of subjects: 46
Study 9286859 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medical or obstetric problems)
Number of subjects: 46
Study 8142112 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoids
Number of subjects: 0
Study 2958072 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine (H1-receptor agonist)
Number of subjects: 15
Study 2958072 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine (combined H1- and H2-receptor agonist)
Number of subjects: 15
Study 2958072 — intervention group
Group type: COMPARATOR
Intervention: Impromidine (H2-receptor agonist)
Number of subjects: 15
Study 30031389 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral dosages of 800 IU vitamin D3
Number of subjects: 60
Study 30031389 — intervention group
Group type: COMPARATOR
Intervention: Single oral dose of 300,000 IU vitamin D3
Number of subjects: 60
Study 27179738 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18140
Study 27179738 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18140
Study 25291578 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 µg of avian influenza Anhui vaccine with MF59 adjuvant
Number of subjects: 637
Study 25291578 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 µg of avian influenza Anhui vaccine without MF59 adjuvant
Number of subjects: 637
Study 25291578 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 µg of antigen with MF59 adjuvant
Number of subjects: 637
Study 25291578 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 µg of unadjuvanted vaccine
Number of subjects: 637
Study 25291578 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 µg plus adjuvant
Number of subjects: 637
Study 25291578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study 22893166 — intervention group
Group type: EXPERIMENTAL
Intervention: COPE plus usual treatment (n = 55)
Number of subjects: 103
Study 22893166 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment alone (control) (n = 48)
Number of subjects: 103
Study 20832701 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide 85 mg
Number of subjects: 343
Study 20832701 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 343
Study 20832701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study 18318243 — intervention group
Group type: EXPERIMENTAL
Intervention: Japanese SF-36v2 acute form
Number of subjects: 210
Study 16650180 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine, 5 mg once daily
Number of subjects: 0
Study 16650180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12477703 — intervention group
Group type: EXPERIMENTAL
Intervention: 'outside head' voices
Number of subjects: 12
Study 12477703 — intervention group
Group type: COMPARATOR
Intervention: 'inside head' voices
Number of subjects: 12
Study 10805616 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine up to 20 mg/day
Number of subjects: 11
Study 10805616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 8859144 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast at school (200 ml of 3%-fat milk and 30 g of sugared cornflakes for 14 days)
Number of subjects: 569
Study 8859144 — intervention group
Group type: COMPARATOR
Intervention: Breakfast at home
Number of subjects: 569
Study 8859144 — intervention group
Group type: COMPARATOR
Intervention: No breakfast
Number of subjects: 569
Study 8859144 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating breakfast 2 hours prior to testing
Number of subjects: 569
Study 8859144 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplementation 30 minutes prior to testing
Number of subjects: 569
Study 8218759 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of ranitidine (50 mg bolus + 0.125 mg.kg/h)
Number of subjects: 18
Study 8218759 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated boluses of ranitidine (50 mg every 6 h)
Number of subjects: 18
Study 8218759 — intervention group
Group type: COMPARATOR
Intervention: Baseline period (no treatment)
Number of subjects: 18
Study 3493738 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclosporin A (CyA) 5 mg/kg body weight for six months
Number of subjects: 14
Study 3493738 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 31364472 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct clinical examination by three different examiners in Phase 1
Number of subjects: 187
Study 31364472 — intervention group
Group type: COMPARATOR
Intervention: Video interpretation of eye examinations by two examiners in Phase 2
Number of subjects: 187
Study 29569459 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Eyeglasses/Earphones System (VEES)
Number of subjects: 36
Study 29569459 — intervention group
Group type: COMPARATOR
Intervention: Traditional non-aversive behaviour management
Number of subjects: 36
Study 26756214 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching performed by flexing the hip while keeping the knee extended (SH)
Number of subjects: 111
Study 26756214 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching performed by first flexing the hip with a flexed knee and then extending the knee (SK)
Number of subjects: 111
Study 26756214 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 111
Study 24342421 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 967
Study 24342421 — intervention group
Group type: COMPARATOR
Intervention: Control group (threshold score of 8)
Number of subjects: 967
Study 24342421 — intervention group
Group type: COMPARATOR
Intervention: Control group (higher thresholds of 12, 16, and 20)
Number of subjects: 967
Study 21692633 — intervention group
Group type: EXPERIMENTAL
Intervention: Human demineralized bone matrix putty with one size of bone particles (SPS)
Number of subjects: 20
Study 21692633 — intervention group
Group type: EXPERIMENTAL
Intervention: Human demineralized bone matrix putty with two different sizes of bone particles (MPS)
Number of subjects: 20
Study 21692633 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SPS and MPS)
Number of subjects: 20
Study 19713332 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (Voluven)
Number of subjects: 90
Study 19713332 — intervention group
Group type: COMPARATOR
Intervention: 4% succinylated gelatin (Gelofusine)
Number of subjects: 90
Study 17125809 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) programme against filariasis
Number of subjects: 2319
Study 15235203 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postoperative naso‐gastric tube feeding with a balanced diet formula
Number of subjects: 200
Study 15235203 — intervention group
Group type: COMPARATOR
Intervention: Conventional regimen of intravenous fluid administration (Control)
Number of subjects: 200
Study 12217069 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapula taping
Number of subjects: 8
Study 12217069 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no scapula taping)
Number of subjects: 8
Study 9631904 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day discharge haemorrhoidectomy (DAY)
Number of subjects: 54
Study 9631904 — intervention group
Group type: COMPARATOR
Intervention: Traditional hospital stay haemorrhoidectomy (STAY)
Number of subjects: 54
Study 8174993 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 12
Study 8174993 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 3163538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (1600 mg/day)
Number of subjects: 45
Study 3163538 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (1600 mg/day) plus Meptazinol (400 mg/day)
Number of subjects: 45
Study 3163538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30446471 — intervention group
Group type: EXPERIMENTAL
Intervention: Water vapor thermal therapy (Rezūm procedure)
Number of subjects: 1295
Study 30446471 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin
Number of subjects: 1295
Study 30446471 — intervention group
Group type: COMPARATOR
Intervention: Finasteride
Number of subjects: 1295
Study 30446471 — intervention group
Group type: COMPARATOR
Intervention: Combination drug therapy
Number of subjects: 1295
Study 30446471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1295
Study 27661412 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-16-5p
Number of subjects: 100
Study 27661412 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-106a-5p
Number of subjects: 100
Study 27661412 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-223-3p
Number of subjects: 100
Study 27661412 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-652-3p
Number of subjects: 100
Study 27661412 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-199a-3p
Number of subjects: 100
Study 27661412 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-18a-5p
Number of subjects: 100
Study 25579623 — intervention group
Group type: EXPERIMENTAL
Intervention: Group medical consultations (GMCs)
Number of subjects: 69
Study 25579623 — intervention group
Group type: COMPARATOR
Intervention: Individual outpatient visits
Number of subjects: 69
Study 23064593 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position with table flat
Number of subjects: 0
Study 23064593 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position with table tilted
Number of subjects: 0
Study 23064593 — intervention group
Group type: COMPARATOR
Intervention: Prone position flat vs. prone position tilted
Number of subjects: 0
Study 23064593 — intervention group
Group type: COMPARATOR
Intervention: Correlation with BMI
Number of subjects: 0
Study 20875125 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment group (lunchtime walking intervention)
Number of subjects: 0
Study 20875125 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 0
Study 18230943 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 60
Study 18230943 — intervention group
Group type: COMPARATOR
Intervention: Rogerian Supportive Therapy (ST)
Number of subjects: 60
Study 16698318 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon amino-caproic acid (EACA)
Number of subjects: 60
Study 16698318 — intervention group
Group type: COMPARATOR
Intervention: Autologous transfusion (AT)
Number of subjects: 60
Study 14639584 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT) with 0.2 mg/kg of alpha‐galactosidase A every 2 weeks
Number of subjects: 26
Study 14639584 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy (ERT)
Number of subjects: 26
Study 10952699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid restriction (about 80% of standard input)
Number of subjects: 168
Study 10952699 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid volumes (60 ml/kg on day 1 progressing to 150 ml/kg on day 7)
Number of subjects: 168
Study 10952699 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid restriction
Number of subjects: 168
Study 10952699 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid volumes
Number of subjects: 168
Study 9003138 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support (intervention calls at 3, 9, and 21 months after cessation clinic quit date)
Number of subjects: 1083
Study 9003138 — intervention group
Group type: COMPARATOR
Intervention: No further intervention (control group)
Number of subjects: 1083
Study 1298545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg once a day (n=13)
Number of subjects: 38
Study 1298545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg once a day + Gemfibrozil 600 mg daily (n=11)
Number of subjects: 38
Study 1298545 — intervention group
Group type: COMPARATOR
Intervention: Diet only (Control group, n=14)
Number of subjects: 38
Study 1298545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg once a day
Number of subjects: 38
Study 1298545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg once a day + Gemfibrozil 600 mg daily
Number of subjects: 38
Study 6209346 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical treatment with 3.5 X 10(4) units of leukocyte interferon/kg (3 injections)
Number of subjects: 55
Study 6209346 — intervention group
Group type: COMPARATOR
Intervention: Postsurgical treatment with placebo (7 injections)
Number of subjects: 55
Study 6209346 — intervention group
Group type: COMPARATOR
Intervention: Placebo (10 injections)
Number of subjects: 55
Study 31257591 — intervention group
Group type: EXPERIMENTAL
Intervention: AMX + MET (500 mg three times a day and 400 mg three times a day for 7 days)
Number of subjects: 46
Study 31257591 — intervention group
Group type: EXPERIMENTAL
Intervention: CLM (500 mg twice a day for 7 days)
Number of subjects: 46
Study 31257591 — intervention group
Group type: COMPARATOR
Intervention: CLM
Number of subjects: 46
Study 29969614 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle intervention (cognitive training, nutrition counseling, and advice on physical activity)
Number of subjects: 1637
Study 29969614 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 1637
Study 26802176 — intervention group
Group type: COMPARATOR
Intervention: MPT-T (melphalan, prednisone, thalidomide)
Number of subjects: 668
Study 26802176 — intervention group
Group type: EXPERIMENTAL
Intervention: MPR-R (melphalan, prednisone, lenalidomide)
Number of subjects: 668
Study 26802176 — intervention group
Group type: COMPARATOR
Intervention: MPT-T
Number of subjects: 668
Study 26802176 — intervention group
Group type: EXPERIMENTAL
Intervention: MPR-R
Number of subjects: 668
Study 24491005 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Zg) for 6 months
Number of subjects: 60
Study 24491005 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pg) for 6 months
Number of subjects: 60
Study 22640773 — intervention group
Group type: EXPERIMENTAL
Intervention: Kana Pick‐out Test (KPT)
Number of subjects: 0
Study 22640773 — intervention group
Group type: COMPARATOR
Intervention: Single task components (reading or vowel pick‐out alone)
Number of subjects: 0
Study 20298652 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA) pulpotomy
Number of subjects: 92
Study 20298652 — intervention group
Group type: COMPARATOR
Intervention: Eugenol-free FS pulpotomy
Number of subjects: 92
Study 20298652 — intervention group
Group type: COMPARATOR
Intervention: Ferric sulfate (FS) pulpotomy
Number of subjects: 92
Study 20298652 — intervention group
Group type: COMPARATOR
Intervention: FS/MTA pulpotomy
Number of subjects: 92
Study 18357902 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation with prosthetics
Number of subjects: 40
Study 18357902 — intervention group
Group type: COMPARATOR
Intervention: Amputated limb
Number of subjects: 40
Study 18357902 — intervention group
Group type: COMPARATOR
Intervention: Non-amputated limb
Number of subjects: 40
Study 18357902 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip flexors
Number of subjects: 40
Study 18357902 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip extensors
Number of subjects: 40